Goldman Sachs Group Inc Jasper Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 14, 2024	BUY	$1.48 - $2.74 $30,742 - $56,915	20,772 Added 202.28%	31,041 $56,000
Q1 2023 May 11, 2023	BUY	$1.48 - $2.74 $45,940 - $85,052	31,041 New	31,041 $56,000
Q2 2022 May 14, 2024	BUY	$1.73 - $3.86 $17,765 - $39,638	10,269 New	10,269 $20,000
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.86 $314 - $702	-182 Reduced 1.74%	10,269 $20,000
Q1 2022 May 16, 2022	SELL	$2.96 - $8.01 $21,602 - $58,456	-7,298 Reduced 41.12%	10,451 $37,000
Q4 2021 Feb 14, 2022	BUY	$7.21 - $16.42 $127,970 - $291,438	17,749 New	17,749 $139,000

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $257M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.